BIOCRYST PHARMACEUTICALS INC (BCRX) › Total AssetsBIOCRYST PHARMACEUTICALS INC (BCRX) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $109.45M2011: $82.21M2012: $57.44M2013: $48.87M2014: $136.87M2015: $122.36M2016: $89.85M2017: $178.26M2018: $146.84M2019: $175.28M2020: $334.71M2021: $588.15M2022: $550.00M2023: $516.96M2024: $490.42M2025: $514.16M$514.16M2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$514.16M+4.8%2024$490.42M-5.1%2023$516.96M-6.0%2022$550.00M-6.5%2021$588.15M+75.7%2020$334.71M+91.0%2019$175.28M+19.4%2018$146.84M-17.6%2017$178.26M+98.4%2016$89.85M-26.6%2015$122.36M-10.6%2014$136.87M+180.1%2013$48.87M-14.9%2012$57.44M-30.1%2011$82.21M-24.9%2010$109.45M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share